CA3299540A1 - Anticorps anti-b7-h3 et leurs utilisations - Google Patents

Anticorps anti-b7-h3 et leurs utilisations

Info

Publication number
CA3299540A1
CA3299540A1 CA3299540A CA3299540A CA3299540A1 CA 3299540 A1 CA3299540 A1 CA 3299540A1 CA 3299540 A CA3299540 A CA 3299540A CA 3299540 A CA3299540 A CA 3299540A CA 3299540 A1 CA3299540 A1 CA 3299540A1
Authority
CA
Canada
Prior art keywords
antibodies
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CA3299540A
Other languages
English (en)
Inventor
Peiran LI
Yanan GUO
Original Assignee
Biocytogen Pharmaceuticals Beijing Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biocytogen Pharmaceuticals Beijing Co Ltd filed Critical Biocytogen Pharmaceuticals Beijing Co Ltd
Publication of CA3299540A1 publication Critical patent/CA3299540A1/fr
Pending legal-status Critical Current

Links

CA3299540A 2023-08-16 2024-08-16 Anticorps anti-b7-h3 et leurs utilisations Pending CA3299540A1 (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
CNPCT/CN2023/113363 2023-08-16
CNPCT/CN2023/113350 2023-08-16
CNPCT/CN2023/113348 2023-08-16
CNPCT/CN2024/105244 2024-07-12

Publications (1)

Publication Number Publication Date
CA3299540A1 true CA3299540A1 (fr) 2025-02-20

Family

ID=

Similar Documents

Publication Publication Date Title
CA3265264A1 (fr) Anticorps anti-ccr8 et leurs utilisations
CA3254156A1 (fr) Anticorps anti-cd84 et leurs utilisations
CA3266237A1 (fr) Anticorps anti-sars-cov2 et leurs utilisations
CA3260932A1 (fr) Anticorps spécifiques de cd25 et leurs utilisations
AU2024380169A1 (en) Anti-muc16 antibodies and uses thereof
AU2024370365A1 (en) Cd40-targetting antibodies and uses thereof
CA3306831A1 (fr) ANTICORPS ANTI-α-SYNUCLÉINE ET LEURS UTILISATIONS
CA3307647A1 (fr) Anticorps anti-il-4 ra et leurs utilisations
AU2024360965A1 (en) Anti-il-4ra antibodies and uses thereof
CA3305834A1 (fr) Anticorps anti-cdh17 et leurs utilisations
CA3304852A1 (fr) Anticorps anti-tigit et leurs utilisations
CA3304830A1 (fr) Anticorps anti-tdp-43 et leurs utilisations
CA3303332A1 (fr) Anticorps anti-ly6 et leurs utilisations
CA3299540A1 (fr) Anticorps anti-b7-h3 et leurs utilisations
CA3299545A1 (fr) Anticorps anti-acvr2b et leurs utilisations
CA3299617A1 (fr) Anticorps et son utilisation
AU2024312447A1 (en) Anti-klrg1 antibodies and uses thereof
CA3296337A1 (fr) Anticorps anti-klrg1 et leurs utilisations
CA3296478A1 (fr) Anticorps et leurs utilisations
HK40131328A (zh) 抗体及其用途
CA3294500A1 (fr) Anticorps anti-pvrig et leurs utilisations
CA3294517A1 (fr) Anticorps anti-tigit et leurs utilisations
CA3291454A1 (fr) Anticorps et leurs utilisations
CA3292497A1 (fr) Anticorps et leurs utilisations
CA3291547A1 (fr) Anticorps ciblant bdca2 et leurs utilisations